ELDICO Scientific is proud to announce the sale of a dedicated ELDICO ED-1 electron diffractometer to Holodiag, a leader in solid-state and crystallisation services for the pharmaceutical industry. The sale marks a significant step in empowering innovative structural-characterisation solutions for the pharma sector – Holodiag will offer electron diffraction as an additional technique for solid-state analysis and screening.
The ED-1 will be deployed not only for solving crystal structures of nanocrystals but also for finding phase impurities and crystalline traces in amorphous substances and elucidating molecular structures – all critical steps for drug development and quality assurance.
This partnership with Holodiag underscores the transformative potential of electron diffraction in the pharmaceutical industry. It is impressive how contract research organisations are driving this change, adding electron diffraction to their portfolio of analytical devices. – Dr James Berwick, CEO, ELDICO Scientific
This instrument is a game-changer for our work in analysing nanocrystalline and complex pharmaceutical materials. It improves our efficiency and ensures unparalleled accuracy in our research and quality-assurance processes. – Pierric Marchand, Founder & General Manager, Holodiag